UBC and CDRD spinout Sitka Biopharma has now lured $5.5m in total and is readying its bladder cancer treatment for initial clinical trials.
Sitka Biopharma, a Canada-based bladder cancer treatment technology spun out of University of British Columbia and life sciences commercialisation agency Centre for Drug Research and Development (CDRD), has secured $1.2m from CDRD. Founded in 2013, Sitka Biopharma is working on cancer drugs that utilise nanoparticle technology to improve absorption in difficult-to-penetrate tissues. The company’s prime…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
